Prostate cancer (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Prostate cancer" in English language version.

Last modified: 03:13:38, 17 August 2026 (UTC)

Ref.Un. Ref.Website

Global rank English rank

4429nih.gov

5^th place

2920doi.org

2^nd place

2218web.archive.org

1^st place

1912cancer.org

4,631^st place

3,828^th place

159worldcat.org

4^th place

72prostatecanceruk.org

low place

44cancerresearchuk.org

9,972^nd place

7,596^th place

32semanticscholar.org

15^th place

8^th place

22ncl.ac.uk

5,403^rd place

3,489^th place

21cancer.net

low place

11cdc.gov

251^st place

248^th place

11nice.org.uk

4,081^st place

3,905^th place

11fda.gov

470^th place

329^th place

11nature.com

207^th place

347^th place

11cancer.gov

1,906^th place

1,649^th place

11kff.org

low place

8,058^th place

11aacrjournals.org

9,401^st place

9,586^th place

11adsabs.harvard.edu

14^th place

9^th place

aacrjournals.org (Global: 9,401^st place; English: 9,586^th place)

cancerres.aacrjournals.org

Huggins CB, Hodges CV (1941). "Studies on Prostate Cancer: 1. The Effects of Castration, of Estrogen and Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the Prostate". Cancer Res. 1 (4): 293. Archived from the original on 30 June 2017. Retrieved 2 September 2015.

adsabs.harvard.edu (Global: 14^th place; English: 9^th place)

ui.adsabs.harvard.edu

Tolis G, Ackman D, Stellos A, Mehta A, Labrie F, Fazekas AT, et al. (March 1982). "Tumor Growth Inhibition in Patients with Prostatic Carcinoma Treated with Luteinizing Hormone-Releasing Hormone Agonists". Proceedings of the National Academy of Sciences of the United States of America. 79 (5): 1658–1662. Bibcode:1982PNAS...79.1658T. doi:10.1073/pnas.79.5.1658. PMC 346035. PMID 6461861.

cancer.gov (Global: 1,906^th place; English: 1,649^th place)

"Cancer Disparities - NCI". www.cancer.gov. 4 August 2016. Retrieved 19 April 2026.

cancer.net (Global: low place; English: low place)

"Care Through the Final Days". American Society of Clinical Oncology. November 2022. Archived from the original on 26 June 2023. Retrieved 25 June 2023.

cancer.org (Global: 4,631^st place; English: 3,828^th place)

"Prostate Cancer Signs and Symptoms". American Cancer Society. 1 August 2019. Retrieved 21 May 2023.
"Screening Tests for Prostate Cancer". American Cancer Society. 4 January 2021. Retrieved 11 December 2023.
"Tests to Diagnose and Stage Prostate Cancer". American Cancer Society. 21 February 2023. Archived from the original on 18 May 2023. Retrieved 18 May 2023.
"Prostate Cancer Staging". American Cancer Society. 8 October 2021. Archived from the original on 15 May 2023. Retrieved 14 May 2023.
"Initial Treatment of Prostate Cancer, by Stage and Risk Group". American Cancer Society. 9 August 2022. Archived from the original on 28 May 2023. Retrieved 28 May 2023.
"Following PSA Levels During and After Prostate Cancer Treatment". American Cancer Society. 1 August 2019. Archived from the original on 28 May 2023. Retrieved 28 May 2023.
"Observation or Active Surveillance for Prostate Cancer". American Cancer Society. 22 November 2023. Archived from the original on 16 April 2024. Retrieved 16 April 2024.
"Radiation Therapy for Prostate Cancer". American Cancer Society. 13 February 2023. Archived from the original on 5 December 2023. Retrieved 5 December 2023.
"Following PSA Levels During and After Prostate Cancer Treatment". American Cancer Society. 1 August 2019. Archived from the original on 7 December 2023. Retrieved 5 December 2023.
"Hormone Therapy for Prostate Cancer". American Cancer Society. 9 August 2022. Archived from the original on 15 May 2023. Retrieved 15 May 2023.
"What Causes Prostate Cancer?". American Cancer Society. 1 August 2019. Archived from the original on 17 May 2023. Retrieved 17 May 2023.
"Understanding Your Pathology Report: Prostatic Intraepithelial Neoplasia (PIN) and Intraductal Carcinoma". American Cancer Society. Retrieved 25 May 2023.

cancerresearchuk.org (Global: 9,972^nd place; English: 7,596^th place)

"Symptoms of Prostate Cancer". Cancer Research UK. 15 March 2022. Archived from the original on 21 May 2023. Retrieved 21 May 2023.
"Prostate Cancer Risk Groups and the Cambridge Prognostic Group (CPG)". Cancer Research UK. 24 May 2022. Archived from the original on 11 August 2023. Retrieved 25 June 2023.
"Locally Advanced Prostate Cancer". Cancer Research UK. 31 May 2022. Archived from the original on 21 May 2023. Retrieved 21 May 2023.
"Prostate Cancer Incidence Statistics". Cancer Research UK. 15 May 2015. Retrieved 2 April 2024.

cdc.gov (Global: 251^st place; English: 248^th place)

"What Is Screening for Prostate Cancer?". U.S. Centers for Disease Control and Prevention. 25 August 2022. Archived from the original on 7 September 2017. Retrieved 17 May 2023.

doi.org (Global: 2^nd place; English: 2^nd place)

Duffy 2020, Table 2. Duffy MJ (February 2020). "Biomarkers for Prostate Cancer: Prostate-Specific Antigen and Beyond". Clin Chem Lab Med. 58 (3): 326–339. doi:10.1515/cclm-2019-0693. PMID 31714881.
Brejt N, Berry J, Nisbet A, Bloomfield D, Burkill G (30 December 2013). "Pelvic radiculopathies, lumbosacral plexopathies, and neuropathies in oncologic disease: a multidisciplinary approach to a diagnostic challenge". Cancer Imaging. 13 (4): 591–601. doi:10.1102/1470-7330.2013.0052. PMC 3893894. PMID 24433993.
Altschuler J, Stocker JA, Kyprianou N (20 February 2021). "RNAs Set a New Phenotypic Frontier in Prostate Cancer Metastasis and Resistance". International Journal of Molecular Sciences. 22 (4). doi:10.3390/ijms22042100. PMC 7924036. PMID 33672595.
Zhu Y, Mo M, Wei Y, Wu J, Pan J, Freedland SJ, et al. (10 March 2021). "Epidemiology and genomics of prostate cancer in Asian men". Nature Reviews Urology. 18 (5): 282–301. doi:10.1038/s41585-021-00442-8. ISSN 1759-4820. PMID 33692499.
Zhu Y, Mo M, Wei Y, Wu J, Pan J, Freedland SJ, et al. (2021). "Epidemiology and genomics of prostate cancer in Asian men". Nature Reviews. Urology. 18 (5): 282–301. doi:10.1038/s41585-021-00442-8. ISSN 1759-4820. PMID 33692499.
Kimura T (2012). "East meets West: ethnic differences in prostate cancer epidemiology between East Asians and Caucasians". Chinese Journal of Cancer. 31 (9): 421–429. doi:10.5732/cjc.011.10324 (inactive 11 August 2026). ISSN 1000-467X. PMC 3777503. PMID 22085526.{{cite journal}}: CS1 maint: DOI inactive as of August 2026 (link)
Cobbs C, Chesnut GT, Shafi AA (30 May 2025). "Understanding Racial Disparities in Prostate Cancer: A Multifaceted Approach". Cancer Medicine. 14 (11) e70979. doi:10.1002/cam4.70979. ISSN 2045-7634. PMC 12123386. PMID 40444484.
Mahal BA, Gerke T, Awasthi S, Soule HR, Simons JW, Miyahira A, et al. (February 2022). "Prostate Cancer Racial Disparities: A Systematic Review by the Prostate Cancer Foundation Panel". European Urology Oncology. 5 (1): 18–29. doi:10.1016/j.euo.2021.07.006. ISSN 2588-9311. PMID 34446369.
Lopez A, Bailey JT, Galloway D, Woods-Burnham L, Montgomery SB, Kittles R, et al. (10 July 2024). "Evidence-based Prostate Cancer Screening Interventions for Black Men: A Systematic Review". Journal of Racial and Ethnic Health Disparities. 12 (4): 2734–2742. doi:10.1007/s40615-024-02085-y. ISSN 2196-8837. PMC 11886399. PMID 38987514.
Vince RA, Jiang R, Bank M, Quarles J, Patel M, Sun Y, et al. (3 January 2023). "Evaluation of Social Determinants of Health and Prostate Cancer Outcomes Among Black and White Patients: A Systematic Review and Meta-analysis". JAMA Network Open. 6 (1): e2250416. doi:10.1001/jamanetworkopen.2022.50416. ISSN 2574-3805. PMC 9857531. PMID 36630135.
Johnson JR, Mavingire N, Woods-Burnham L, Walker M, Lewis D, Hooker SE, et al. (2 February 2024). "The complex interplay of modifiable risk factors affecting prostate cancer disparities in African American men". Nature Reviews. Urology. 21 (7): 422–432. doi:10.1038/s41585-023-00849-5. ISSN 1759-4820. PMC 11904840. PMID 38307952.
Basourakos SP, Gulati R, Vince RA, Spratt DE, Lewicki PJ, Hill A, et al. (June 2022). "Harm-to-Benefit of Three Decades of Prostate Cancer Screening in Black Men". NEJM Evidence. 1 (6). doi:10.1056/evidoa2200031. ISSN 2766-5526. PMC 9202998. PMID 35721307.
Lawrence W (1817). "Cases of Fungus Hæmatodes, with Observations, by George Langstaff, Esq. and an Appendix, Containing two Cases of Analogous Affections". Med Chir Trans. 8: 272–314. doi:10.1177/095952871700800114. PMC 2129005. PMID 20895322.
Adams J (1853). "The Case of Scirrhous of the Prostate Gland with Corresponding Affliction of the Lymphatic Glands in the Lumbar Region and in the Pelvis". Lancet. 1 (1547): 393–94. doi:10.1016/S0140-6736(02)68759-8.
Lytton 2001, p. 1859. Lytton B (June 2001). "Prostate cancer: a brief history and the discovery of hormonal ablation treatment". The Journal of Urology. 165 (6 Pt 1): 1859–1862. doi:10.1016/S0022-5347(05)66228-3. PMID 11371867.
Walsh PC, Lepor H, Eggleston JC (1983). "Radical Prostatectomy with Preservation of Sexual Function: Anatomical and Pathological Considerations". The Prostate. 4 (5): 473–485. doi:10.1002/pros.2990040506. PMID 6889192. S2CID 30740301.
Tolis G, Ackman D, Stellos A, Mehta A, Labrie F, Fazekas AT, et al. (March 1982). "Tumor Growth Inhibition in Patients with Prostatic Carcinoma Treated with Luteinizing Hormone-Releasing Hormone Agonists". Proceedings of the National Academy of Sciences of the United States of America. 79 (5): 1658–1662. Bibcode:1982PNAS...79.1658T. doi:10.1073/pnas.79.5.1658. PMC 346035. PMID 6461861.
Patel et al. 2020, p. 64. Patel MS, Halpern JA, Desai AS, Keeter MK, Bennett NE, Brannigan RE (May 2020). "Success of Prostate and Testicular Cancer Awareness Campaigns Compared to Breast Cancer Awareness Month According to Internet Search Volumes: A Google Trends Analysis". Urology. 139: 64–70. doi:10.1016/j.urology.2019.11.062. PMID 32001306. S2CID 210982209.
McIntosh et al. 2023, Table 1. McIntosh SA, Alam F, Adams L, Boon IS, Callaghan J, Conti I, et al. (June 2023). "Global Funding for Cancer Research Between 2016 and 2020: a Content Analysis of Public and Philanthropic Investments". Lancet Oncol. 24 (6): 636–645. doi:10.1016/S1470-2045(23)00182-1. PMID 37269844.
McIntosh et al. 2023, Table 2. McIntosh SA, Alam F, Adams L, Boon IS, Callaghan J, Conti I, et al. (June 2023). "Global Funding for Cancer Research Between 2016 and 2020: a Content Analysis of Public and Philanthropic Investments". Lancet Oncol. 24 (6): 636–645. doi:10.1016/S1470-2045(23)00182-1. PMID 37269844.

fda.gov (Global: 470^th place; English: 329^th place)

"FDA Approves Pluvicto for Metastatic Castration-Resistant Prostate Cancer". U.S. Food & Drug Administration. 23 March 2022. Archived from the original on 24 March 2022. Retrieved 9 January 2024.

kff.org (Global: low place; English: 8,058^th place)

kffmichellet (3 February 2022). "Racial Disparities in Cancer Outcomes, Screening, and Treatment". KFF. Retrieved 19 April 2026.

nature.com (Global: 207^th place; English: 347^th place)

Zhu Y, Mo M, Wei Y, Wu J, Pan J, Freedland SJ, et al. (10 March 2021). "Epidemiology and genomics of prostate cancer in Asian men". Nature Reviews Urology. 18 (5): 282–301. doi:10.1038/s41585-021-00442-8. ISSN 1759-4820. PMID 33692499.

ncl.ac.uk (Global: 5,403^rd place; English: 3,489^th place)

eprints.ncl.ac.uk

McIntosh et al. 2023, Table 1. McIntosh SA, Alam F, Adams L, Boon IS, Callaghan J, Conti I, et al. (June 2023). "Global Funding for Cancer Research Between 2016 and 2020: a Content Analysis of Public and Philanthropic Investments". Lancet Oncol. 24 (6): 636–645. doi:10.1016/S1470-2045(23)00182-1. PMID 37269844.
McIntosh et al. 2023, Table 2. McIntosh SA, Alam F, Adams L, Boon IS, Callaghan J, Conti I, et al. (June 2023). "Global Funding for Cancer Research Between 2016 and 2020: a Content Analysis of Public and Philanthropic Investments". Lancet Oncol. 24 (6): 636–645. doi:10.1016/S1470-2045(23)00182-1. PMID 37269844.

nice.org.uk (Global: 4,081^st place; English: 3,905^th place)

"Prostate Cancer: Diagnosis and Management. NICE Guideline [NG131]". National Institute for Health and Care Excellence (NICE). 9 May 2019. Archived from the original on 11 August 2023. Retrieved 3 October 2022.

nih.gov (Global: 5^th place; English: 5^th place)

pubmed.ncbi.nlm.nih.gov

Duffy 2020, Table 2. Duffy MJ (February 2020). "Biomarkers for Prostate Cancer: Prostate-Specific Antigen and Beyond". Clin Chem Lab Med. 58 (3): 326–339. doi:10.1515/cclm-2019-0693. PMID 31714881.
Brejt N, Berry J, Nisbet A, Bloomfield D, Burkill G (30 December 2013). "Pelvic radiculopathies, lumbosacral plexopathies, and neuropathies in oncologic disease: a multidisciplinary approach to a diagnostic challenge". Cancer Imaging. 13 (4): 591–601. doi:10.1102/1470-7330.2013.0052. PMC 3893894. PMID 24433993.
Altschuler J, Stocker JA, Kyprianou N (20 February 2021). "RNAs Set a New Phenotypic Frontier in Prostate Cancer Metastasis and Resistance". International Journal of Molecular Sciences. 22 (4). doi:10.3390/ijms22042100. PMC 7924036. PMID 33672595.
Zhu Y, Mo M, Wei Y, Wu J, Pan J, Freedland SJ, et al. (10 March 2021). "Epidemiology and genomics of prostate cancer in Asian men". Nature Reviews Urology. 18 (5): 282–301. doi:10.1038/s41585-021-00442-8. ISSN 1759-4820. PMID 33692499.
Zhu Y, Mo M, Wei Y, Wu J, Pan J, Freedland SJ, et al. (2021). "Epidemiology and genomics of prostate cancer in Asian men". Nature Reviews. Urology. 18 (5): 282–301. doi:10.1038/s41585-021-00442-8. ISSN 1759-4820. PMID 33692499.
Kimura T (2012). "East meets West: ethnic differences in prostate cancer epidemiology between East Asians and Caucasians". Chinese Journal of Cancer. 31 (9): 421–429. doi:10.5732/cjc.011.10324 (inactive 11 August 2026). ISSN 1000-467X. PMC 3777503. PMID 22085526.{{cite journal}}: CS1 maint: DOI inactive as of August 2026 (link)
Cobbs C, Chesnut GT, Shafi AA (30 May 2025). "Understanding Racial Disparities in Prostate Cancer: A Multifaceted Approach". Cancer Medicine. 14 (11) e70979. doi:10.1002/cam4.70979. ISSN 2045-7634. PMC 12123386. PMID 40444484.
Mahal BA, Gerke T, Awasthi S, Soule HR, Simons JW, Miyahira A, et al. (February 2022). "Prostate Cancer Racial Disparities: A Systematic Review by the Prostate Cancer Foundation Panel". European Urology Oncology. 5 (1): 18–29. doi:10.1016/j.euo.2021.07.006. ISSN 2588-9311. PMID 34446369.
Lopez A, Bailey JT, Galloway D, Woods-Burnham L, Montgomery SB, Kittles R, et al. (10 July 2024). "Evidence-based Prostate Cancer Screening Interventions for Black Men: A Systematic Review". Journal of Racial and Ethnic Health Disparities. 12 (4): 2734–2742. doi:10.1007/s40615-024-02085-y. ISSN 2196-8837. PMC 11886399. PMID 38987514.
Vince RA, Jiang R, Bank M, Quarles J, Patel M, Sun Y, et al. (3 January 2023). "Evaluation of Social Determinants of Health and Prostate Cancer Outcomes Among Black and White Patients: A Systematic Review and Meta-analysis". JAMA Network Open. 6 (1): e2250416. doi:10.1001/jamanetworkopen.2022.50416. ISSN 2574-3805. PMC 9857531. PMID 36630135.
Johnson JR, Mavingire N, Woods-Burnham L, Walker M, Lewis D, Hooker SE, et al. (2 February 2024). "The complex interplay of modifiable risk factors affecting prostate cancer disparities in African American men". Nature Reviews. Urology. 21 (7): 422–432. doi:10.1038/s41585-023-00849-5. ISSN 1759-4820. PMC 11904840. PMID 38307952.
Basourakos SP, Gulati R, Vince RA, Spratt DE, Lewicki PJ, Hill A, et al. (June 2022). "Harm-to-Benefit of Three Decades of Prostate Cancer Screening in Black Men". NEJM Evidence. 1 (6). doi:10.1056/evidoa2200031. ISSN 2766-5526. PMC 9202998. PMID 35721307.
Lawrence W (1817). "Cases of Fungus Hæmatodes, with Observations, by George Langstaff, Esq. and an Appendix, Containing two Cases of Analogous Affections". Med Chir Trans. 8: 272–314. doi:10.1177/095952871700800114. PMC 2129005. PMID 20895322.
Lytton 2001, p. 1859. Lytton B (June 2001). "Prostate cancer: a brief history and the discovery of hormonal ablation treatment". The Journal of Urology. 165 (6 Pt 1): 1859–1862. doi:10.1016/S0022-5347(05)66228-3. PMID 11371867.
Walsh PC, Lepor H, Eggleston JC (1983). "Radical Prostatectomy with Preservation of Sexual Function: Anatomical and Pathological Considerations". The Prostate. 4 (5): 473–485. doi:10.1002/pros.2990040506. PMID 6889192. S2CID 30740301.
Tolis G, Ackman D, Stellos A, Mehta A, Labrie F, Fazekas AT, et al. (March 1982). "Tumor Growth Inhibition in Patients with Prostatic Carcinoma Treated with Luteinizing Hormone-Releasing Hormone Agonists". Proceedings of the National Academy of Sciences of the United States of America. 79 (5): 1658–1662. Bibcode:1982PNAS...79.1658T. doi:10.1073/pnas.79.5.1658. PMC 346035. PMID 6461861.
Patel et al. 2020, p. 64. Patel MS, Halpern JA, Desai AS, Keeter MK, Bennett NE, Brannigan RE (May 2020). "Success of Prostate and Testicular Cancer Awareness Campaigns Compared to Breast Cancer Awareness Month According to Internet Search Volumes: A Google Trends Analysis". Urology. 139: 64–70. doi:10.1016/j.urology.2019.11.062. PMID 32001306. S2CID 210982209.
McIntosh et al. 2023, Table 1. McIntosh SA, Alam F, Adams L, Boon IS, Callaghan J, Conti I, et al. (June 2023). "Global Funding for Cancer Research Between 2016 and 2020: a Content Analysis of Public and Philanthropic Investments". Lancet Oncol. 24 (6): 636–645. doi:10.1016/S1470-2045(23)00182-1. PMID 37269844.
McIntosh et al. 2023, Table 2. McIntosh SA, Alam F, Adams L, Boon IS, Callaghan J, Conti I, et al. (June 2023). "Global Funding for Cancer Research Between 2016 and 2020: a Content Analysis of Public and Philanthropic Investments". Lancet Oncol. 24 (6): 636–645. doi:10.1016/S1470-2045(23)00182-1. PMID 37269844.

ncbi.nlm.nih.gov

Brejt N, Berry J, Nisbet A, Bloomfield D, Burkill G (30 December 2013). "Pelvic radiculopathies, lumbosacral plexopathies, and neuropathies in oncologic disease: a multidisciplinary approach to a diagnostic challenge". Cancer Imaging. 13 (4): 591–601. doi:10.1102/1470-7330.2013.0052. PMC 3893894. PMID 24433993.
Altschuler J, Stocker JA, Kyprianou N (20 February 2021). "RNAs Set a New Phenotypic Frontier in Prostate Cancer Metastasis and Resistance". International Journal of Molecular Sciences. 22 (4). doi:10.3390/ijms22042100. PMC 7924036. PMID 33672595.
Kimura T (2012). "East meets West: ethnic differences in prostate cancer epidemiology between East Asians and Caucasians". Chinese Journal of Cancer. 31 (9): 421–429. doi:10.5732/cjc.011.10324 (inactive 11 August 2026). ISSN 1000-467X. PMC 3777503. PMID 22085526.{{cite journal}}: CS1 maint: DOI inactive as of August 2026 (link)
Cobbs C, Chesnut GT, Shafi AA (30 May 2025). "Understanding Racial Disparities in Prostate Cancer: A Multifaceted Approach". Cancer Medicine. 14 (11) e70979. doi:10.1002/cam4.70979. ISSN 2045-7634. PMC 12123386. PMID 40444484.
Lopez A, Bailey JT, Galloway D, Woods-Burnham L, Montgomery SB, Kittles R, et al. (10 July 2024). "Evidence-based Prostate Cancer Screening Interventions for Black Men: A Systematic Review". Journal of Racial and Ethnic Health Disparities. 12 (4): 2734–2742. doi:10.1007/s40615-024-02085-y. ISSN 2196-8837. PMC 11886399. PMID 38987514.
Vince RA, Jiang R, Bank M, Quarles J, Patel M, Sun Y, et al. (3 January 2023). "Evaluation of Social Determinants of Health and Prostate Cancer Outcomes Among Black and White Patients: A Systematic Review and Meta-analysis". JAMA Network Open. 6 (1): e2250416. doi:10.1001/jamanetworkopen.2022.50416. ISSN 2574-3805. PMC 9857531. PMID 36630135.
Johnson JR, Mavingire N, Woods-Burnham L, Walker M, Lewis D, Hooker SE, et al. (2 February 2024). "The complex interplay of modifiable risk factors affecting prostate cancer disparities in African American men". Nature Reviews. Urology. 21 (7): 422–432. doi:10.1038/s41585-023-00849-5. ISSN 1759-4820. PMC 11904840. PMID 38307952.
Basourakos SP, Gulati R, Vince RA, Spratt DE, Lewicki PJ, Hill A, et al. (June 2022). "Harm-to-Benefit of Three Decades of Prostate Cancer Screening in Black Men". NEJM Evidence. 1 (6). doi:10.1056/evidoa2200031. ISSN 2766-5526. PMC 9202998. PMID 35721307.
Lawrence W (1817). "Cases of Fungus Hæmatodes, with Observations, by George Langstaff, Esq. and an Appendix, Containing two Cases of Analogous Affections". Med Chir Trans. 8: 272–314. doi:10.1177/095952871700800114. PMC 2129005. PMID 20895322.
Tolis G, Ackman D, Stellos A, Mehta A, Labrie F, Fazekas AT, et al. (March 1982). "Tumor Growth Inhibition in Patients with Prostatic Carcinoma Treated with Luteinizing Hormone-Releasing Hormone Agonists". Proceedings of the National Academy of Sciences of the United States of America. 79 (5): 1658–1662. Bibcode:1982PNAS...79.1658T. doi:10.1073/pnas.79.5.1658. PMC 346035. PMID 6461861.

prostatecanceruk.org (Global: low place; English: low place)

"What is Metastatic Spinal Cord Compression (MSCC)?". Prostate Cancer UK. June 2022. Archived from the original on 26 June 2023. Retrieved 25 June 2023.
"Dying from Prostate Cancer – What to Expect". Prostate Cancer UK. July 2018. Retrieved 25 June 2023.

semanticscholar.org (Global: 15^th place; English: 8^th place)

api.semanticscholar.org

Walsh PC, Lepor H, Eggleston JC (1983). "Radical Prostatectomy with Preservation of Sexual Function: Anatomical and Pathological Considerations". The Prostate. 4 (5): 473–485. doi:10.1002/pros.2990040506. PMID 6889192. S2CID 30740301.
Patel et al. 2020, p. 64. Patel MS, Halpern JA, Desai AS, Keeter MK, Bennett NE, Brannigan RE (May 2020). "Success of Prostate and Testicular Cancer Awareness Campaigns Compared to Breast Cancer Awareness Month According to Internet Search Volumes: A Google Trends Analysis". Urology. 139: 64–70. doi:10.1016/j.urology.2019.11.062. PMID 32001306. S2CID 210982209.

web.archive.org (Global: 1^st place; English: 1^st place)

"Symptoms of Prostate Cancer". Cancer Research UK. 15 March 2022. Archived from the original on 21 May 2023. Retrieved 21 May 2023.
"What Is Screening for Prostate Cancer?". U.S. Centers for Disease Control and Prevention. 25 August 2022. Archived from the original on 7 September 2017. Retrieved 17 May 2023.
"Tests to Diagnose and Stage Prostate Cancer". American Cancer Society. 21 February 2023. Archived from the original on 18 May 2023. Retrieved 18 May 2023.
"Prostate Cancer Staging". American Cancer Society. 8 October 2021. Archived from the original on 15 May 2023. Retrieved 14 May 2023.
"Prostate Cancer: Diagnosis and Management. NICE Guideline [NG131]". National Institute for Health and Care Excellence (NICE). 9 May 2019. Archived from the original on 11 August 2023. Retrieved 3 October 2022.
"Prostate Cancer Risk Groups and the Cambridge Prognostic Group (CPG)". Cancer Research UK. 24 May 2022. Archived from the original on 11 August 2023. Retrieved 25 June 2023.
"Initial Treatment of Prostate Cancer, by Stage and Risk Group". American Cancer Society. 9 August 2022. Archived from the original on 28 May 2023. Retrieved 28 May 2023.
"Following PSA Levels During and After Prostate Cancer Treatment". American Cancer Society. 1 August 2019. Archived from the original on 28 May 2023. Retrieved 28 May 2023.
"Observation or Active Surveillance for Prostate Cancer". American Cancer Society. 22 November 2023. Archived from the original on 16 April 2024. Retrieved 16 April 2024.
"Radiation Therapy for Prostate Cancer". American Cancer Society. 13 February 2023. Archived from the original on 5 December 2023. Retrieved 5 December 2023.
"Following PSA Levels During and After Prostate Cancer Treatment". American Cancer Society. 1 August 2019. Archived from the original on 7 December 2023. Retrieved 5 December 2023.
"Hormone Therapy for Prostate Cancer". American Cancer Society. 9 August 2022. Archived from the original on 15 May 2023. Retrieved 15 May 2023.
"FDA Approves Pluvicto for Metastatic Castration-Resistant Prostate Cancer". U.S. Food & Drug Administration. 23 March 2022. Archived from the original on 24 March 2022. Retrieved 9 January 2024.
"What is Metastatic Spinal Cord Compression (MSCC)?". Prostate Cancer UK. June 2022. Archived from the original on 26 June 2023. Retrieved 25 June 2023.
"Care Through the Final Days". American Society of Clinical Oncology. November 2022. Archived from the original on 26 June 2023. Retrieved 25 June 2023.
"What Causes Prostate Cancer?". American Cancer Society. 1 August 2019. Archived from the original on 17 May 2023. Retrieved 17 May 2023.
"Locally Advanced Prostate Cancer". Cancer Research UK. 31 May 2022. Archived from the original on 21 May 2023. Retrieved 21 May 2023.
Huggins CB, Hodges CV (1941). "Studies on Prostate Cancer: 1. The Effects of Castration, of Estrogen and Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the Prostate". Cancer Res. 1 (4): 293. Archived from the original on 30 June 2017. Retrieved 2 September 2015.

worldcat.org (Global: 4^th place; English: 4^th place)

search.worldcat.org

Zhu Y, Mo M, Wei Y, Wu J, Pan J, Freedland SJ, et al. (10 March 2021). "Epidemiology and genomics of prostate cancer in Asian men". Nature Reviews Urology. 18 (5): 282–301. doi:10.1038/s41585-021-00442-8. ISSN 1759-4820. PMID 33692499.
Zhu Y, Mo M, Wei Y, Wu J, Pan J, Freedland SJ, et al. (2021). "Epidemiology and genomics of prostate cancer in Asian men". Nature Reviews. Urology. 18 (5): 282–301. doi:10.1038/s41585-021-00442-8. ISSN 1759-4820. PMID 33692499.
Kimura T (2012). "East meets West: ethnic differences in prostate cancer epidemiology between East Asians and Caucasians". Chinese Journal of Cancer. 31 (9): 421–429. doi:10.5732/cjc.011.10324 (inactive 11 August 2026). ISSN 1000-467X. PMC 3777503. PMID 22085526.{{cite journal}}: CS1 maint: DOI inactive as of August 2026 (link)
Cobbs C, Chesnut GT, Shafi AA (30 May 2025). "Understanding Racial Disparities in Prostate Cancer: A Multifaceted Approach". Cancer Medicine. 14 (11) e70979. doi:10.1002/cam4.70979. ISSN 2045-7634. PMC 12123386. PMID 40444484.
Mahal BA, Gerke T, Awasthi S, Soule HR, Simons JW, Miyahira A, et al. (February 2022). "Prostate Cancer Racial Disparities: A Systematic Review by the Prostate Cancer Foundation Panel". European Urology Oncology. 5 (1): 18–29. doi:10.1016/j.euo.2021.07.006. ISSN 2588-9311. PMID 34446369.
Lopez A, Bailey JT, Galloway D, Woods-Burnham L, Montgomery SB, Kittles R, et al. (10 July 2024). "Evidence-based Prostate Cancer Screening Interventions for Black Men: A Systematic Review". Journal of Racial and Ethnic Health Disparities. 12 (4): 2734–2742. doi:10.1007/s40615-024-02085-y. ISSN 2196-8837. PMC 11886399. PMID 38987514.
Vince RA, Jiang R, Bank M, Quarles J, Patel M, Sun Y, et al. (3 January 2023). "Evaluation of Social Determinants of Health and Prostate Cancer Outcomes Among Black and White Patients: A Systematic Review and Meta-analysis". JAMA Network Open. 6 (1): e2250416. doi:10.1001/jamanetworkopen.2022.50416. ISSN 2574-3805. PMC 9857531. PMID 36630135.
Johnson JR, Mavingire N, Woods-Burnham L, Walker M, Lewis D, Hooker SE, et al. (2 February 2024). "The complex interplay of modifiable risk factors affecting prostate cancer disparities in African American men". Nature Reviews. Urology. 21 (7): 422–432. doi:10.1038/s41585-023-00849-5. ISSN 1759-4820. PMC 11904840. PMID 38307952.
Basourakos SP, Gulati R, Vince RA, Spratt DE, Lewicki PJ, Hill A, et al. (June 2022). "Harm-to-Benefit of Three Decades of Prostate Cancer Screening in Black Men". NEJM Evidence. 1 (6). doi:10.1056/evidoa2200031. ISSN 2766-5526. PMC 9202998. PMID 35721307.

Prostate cancer (English Wikipedia)

aacrjournals.org (Global: 9,401st place; English: 9,586th place)

cancerres.aacrjournals.org

adsabs.harvard.edu (Global: 14th place; English: 9th place)

ui.adsabs.harvard.edu

cancer.gov (Global: 1,906th place; English: 1,649th place)

cancer.net (Global: low place; English: low place)

cancer.org (Global: 4,631st place; English: 3,828th place)

cancerresearchuk.org (Global: 9,972nd place; English: 7,596th place)

cdc.gov (Global: 251st place; English: 248th place)

doi.org (Global: 2nd place; English: 2nd place)

fda.gov (Global: 470th place; English: 329th place)

kff.org (Global: low place; English: 8,058th place)

nature.com (Global: 207th place; English: 347th place)

ncl.ac.uk (Global: 5,403rd place; English: 3,489th place)

eprints.ncl.ac.uk

nice.org.uk (Global: 4,081st place; English: 3,905th place)

nih.gov (Global: 5th place; English: 5th place)

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

prostatecanceruk.org (Global: low place; English: low place)

semanticscholar.org (Global: 15th place; English: 8th place)

api.semanticscholar.org

web.archive.org (Global: 1st place; English: 1st place)

worldcat.org (Global: 4th place; English: 4th place)

search.worldcat.org

aacrjournals.org (Global: 9,401^st place; English: 9,586^th place)

adsabs.harvard.edu (Global: 14^th place; English: 9^th place)

cancer.gov (Global: 1,906^th place; English: 1,649^th place)

cancer.org (Global: 4,631^st place; English: 3,828^th place)

cancerresearchuk.org (Global: 9,972^nd place; English: 7,596^th place)

cdc.gov (Global: 251^st place; English: 248^th place)

doi.org (Global: 2^nd place; English: 2^nd place)

fda.gov (Global: 470^th place; English: 329^th place)

kff.org (Global: low place; English: 8,058^th place)

nature.com (Global: 207^th place; English: 347^th place)

ncl.ac.uk (Global: 5,403^rd place; English: 3,489^th place)

nice.org.uk (Global: 4,081^st place; English: 3,905^th place)

nih.gov (Global: 5^th place; English: 5^th place)

semanticscholar.org (Global: 15^th place; English: 8^th place)

web.archive.org (Global: 1^st place; English: 1^st place)

worldcat.org (Global: 4^th place; English: 4^th place)